Prescription Dermatological Drugs: Worldwide Market
This report provides the reader with a complete analysis of the US and international markets for pharmaceuticals to treat skin diseases and disorders. The report focuses on:
- Acne and Rosacea
- Antiaging and Photodamage
- Dermatitis and Seborrhea
- Fungal Infections
- Hair Loss and Hair Removal
- Hyperpigmentation/Melasma
- Psoriasis
- Skin Cancer, and
- Other Skin Disorders
Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:
- United States
- Europe
- Japan
- Rest of world
The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:
- Allergan Inc.
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bayer AG
- Bradley Pharmaceuticals, Inc
- Bristol-Myers Squibb
- CollaGenex Pharmaceuticals
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Nycomed Inc.
- Pfizer, Inc.
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- Sinclair Pharma Plc.
- SkinMedica
- Stiefel Laboratories, Inc.
- Valeant Pharmaceuticals, Inc.
Table of Contents
Chapter One: Executive Summary
- Scope and Methodology
- Size and Growth of the Market
- Issues and Trends Affecting Market
- Competitor Analysis
Chapter Two: Introduction
- Structure and Function of the Skin
- Epidermis
- Dermis
- Subcutaneous Tissue
- Epidermal Appendages
- Functions of the Skin
- Effects of Aging on the Skin
- Dermatological Conditions and Treatment
- Pharmacokinetics
- Drug Absorption
- Distribution
- Bioavailability
- Drug Delivery Methods
- Demographics of Skin Disorders, Incidence, and Prevalence
Chapter Three: Issues and Trends
- Cosmetic Dermatologists
- Medicare Reimbursement
- Melanoma Survival Rates Falter
- New Filler Options
- A Confusing Industry
- Genetic Link to Psoriasis
- Biologic Dermatology
- Rx-to-OTC Switches
- Cosmeceuticals
- Antioxidants
- Polypeptides
- Teledermatology
- Reimbursement Issues
- Laser Therapy
- Narrowband Ultraviolet B
- Photodynamic Therapy
- Importance of Drug Delivery
Chapter Four: Prescription Antiacne and Rosacea Drugs
- Description of Disorders
- Description of Products
- Benzoyl Peroxide
- Description of Products
- Current Suppliers
- Retinoids
- Topical Formulations
- All-trans Retinoic Acid (Tretinoin)
- Adapalene
- Tazarotene
- Systemic Formulations
- Isotretinoin
- Current Suppliers
- Topical Formulations
- Antibiotics
- Description of Products
- Azelaic Acid
- Clindamycin
- Erythromycin
- Metronidazole
- Sodium Sulfacetamide
- Current Suppliers
- Description of Products
- Oral Contraceptives
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
Chapter Five: Prescription Antiaging and Photodamage Drugs
- Overview
- Description of Products
- Keratolytics
- Moisturizers
- Retinoids
- Sunscreens
- Other Agents
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
Chapter Six: Prescription Dermatitis and Seborrhea Drugs
- Overview
- Description of Products
- Topical Corticosteroids
- Systemic Corticosteroids
- Other Products
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
Chapter Seven: Prescription Antifungal Drugs
- Overview
- Description of Products
- Systemic Formulations
- Terbinafine
- Itraconazole
- Fluconazole
- Griseofulvin
- Ketoconazole
- Current Suppliers
- Topical Formulations
- Polyenes
- Azoles
- Miconazole
- Clotrimazole
- Ketoconazole
- Oxiconazole
- Econazole
- Sulconazole
- Allylamines and Benzylamines
- Naftifine
- Terbinafine
- Butenafine
- Other Topical Formulations
- Current Suppliers
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
- Overview
- Description of Products
- Antiandrogens
- Androgen Inhibitors
- Oral Contraceptives
- Other Treatments
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
- Overview
- Description of Products
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
Chapter Ten: Prescription Psoriasis Drugs
- Overview
- Description of Products
- Topical Psoriasis Products
- Anthralin
- Coal Tar
- Methoxsalen
- Second-generation Retinoids
- Tazarotene
- Topical Vitamin D
- Vitamin D Analogs
- Vanos
- Systemic Psoriasis Preparations
- Betamethasone
- Cortisone Acetate
- Cyclosporine
- Hydrocortisone
- Methotrexate
- Olopatadine Hydrochloride
- Tacrolimus
- Light Therapy
- Biologics
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
Chapter Eleven: Prescription Skin Cancer Drugs
- Overview
- Nonmelanoma Skin Cancers
- Actinic Keratoses
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Cutaneous T-cell Lymphoma
- Dysplastic Nevus Syndrome
- Malignant Melanoma
- Description of Products
- 5-Fluorouracil
- Mechlorethamine/Nitrogen Mustard
- Carmustine/BCNU (Topical)
- Vinblastine (Intralesional) and Others
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
Chapter Twelve: Miscellaneous Skin Disorder Drugs—Antivirals and Antiparasitics
- Overview
- Antivirals
- Antiparasitics
- Description of Products
- Topical Antivirals
- Antiviral Drugs
- Immunoenhancing Drugs
- Current Suppliers
- Antiparasitic Agents
- Current Suppliers
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
Chapter Thirteen: World Market Summary
- Overview
- Total Market Size and Forecast
- Market and Competitive Analysis
Chapter Fourteen: Corporate Profiles
- Allergan Inc.
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bayer AG
- Bradley Pharmaceuticals, Inc
- Bristol-Myers Squibb
- CollaGenex Pharmaceuticals
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Nycomed Inc.
- Pfizer, Inc.
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- Sinclair Pharma Plc.
- SkinMedica
- Stiefel Laboratories, Inc.
- Valeant Pharmaceuticals, Inc.
Appendix: Company Directory
List of Exhibits
Chapter One: Executive Summary
- Table 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011
- Figure 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011
Chapter Two: Introduction
- Table 2-1: Common Bases for Topical Dermatological Medications
- Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions
Chapter Three: Issues and Trends
- Table 3-1: Selected Dermatological Rx-to-OTC Switches
- Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC Switches
Chapter Four: Prescription Antiacne and Rosacea Drugs
- Table 4-1: Common Benzoyl Peroxide Formulations
- Table 4-2: Common Retinoid Formulations
- Table 4-3: Common Antibiotic Formulations
- Table 4-4: Common Oral Contraceptive Formulations
- Table 4-5: Prescription Acne and Rosacea Formulations in Development
- Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 2002-2011
- Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs Revenues by Type 2000-2010
- Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2006
- Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2011
- Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2000-2011
- Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 2000-2011
- Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2006
- Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2011
- Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2006
- Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2006
Chapter Five: Prescription Antiaging and Photodamage Drugs
- Table 5-1: Common Prescription Keratolytic Formulations
- Table 5-2: Occlusive Moisturizers—Categories of Ingredients
- Table 5-3: Common Prescription Moisturizers
- Table 5-4: Common Prescription Retinoids for Antiaging andPhotodamage
- Table 5-5: Common Prescription Sunscreens
- Table 5-6: Other Prescription Antiaging and Photodamage Products
- Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 2000-2011
- Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 2000-2011
- Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2006
- Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2011
- Table 5-10: The Global Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 2000-2006
- Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs, Revenues by Geographical Region 2000-2011
- Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2006
- Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2011
- Table 5-16: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2006
- Figure 5-7: Global Market for Prescription Antiaging and Photodamage Drugs, Market Share by Leading Supplier 2006
Chapter Six: Prescription Dermatitis and Seborrhea Drugs
- Table 6-1: Common Prescription Topical Corticosteroid Preparations
- Table 6-2: Common Prescription Systemic Corticosteroids
- Table 6-3: Prescription Dermatitis Formulations in Development
- Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 2000-2011
- Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 2002-2011
- Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2006
- Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2011
- Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 2002-2011
- Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 2002-2011
- Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2006
- Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2011
- Table 6-12: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2002
- Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2006
Chapter Seven: Prescription Antifungal Drugs
- Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
- Table 7-2: Common Prescription Topical Antifungal DermatologicalDrugs
- Table 7-3: Prescription Antifungal Dermatological Drugs inDevelopment
- Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 2002-2011
- Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 2002-2011
- Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2006
- Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2011
- Table 7-6: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2002-2006
- Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 2002-2006
- Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2006
- Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2011
- Table 7-12: Global Market for Prescription Antifungal DermatologicalDrugs Revenues and Market Share by Supplier 2006
- Figure 7-7: Global Market for Prescription Antifungal Dermatological
- Drugs Market Share by Leading Supplier 2006
Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
- Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
- Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development
- Table 8-3: The Global Market for Prescription Hair Loss and HairRemoval Drugs by Type 2002-2011
- Figure 8-1: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Type 2002-2011
- Figure 8-2: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs, Share by Type 2006
- Figure 8-3: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs, Share by Type 2011
- Table 8-5: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Geographical Region 2002-2011
- Figure 8-4: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Geographical Region 2002-2011
- Figure 8-5: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Share by Geographical Region 2006
- Figure 8-6: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Share by Geographical Region 2011
- Table 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2006
- Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2006
Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
- Table 9-1: Common Prescription Hyperpigmentation/Melasma
- Formulations
- Table 9-2: Common Prescription Depigmenting Agents
- Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 2002-2012
- Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 2002-2012
- Figure 9-2: The Global Market for Prescription Hyperpigmentation/Melasma Drugs, Share by Type 2006
- Figure 9-3: The Global Market for Prescription Hyperpigmentation/Melasma Drugs Share by Type 2011
- Table 9-5: The Global Market for Prescription Hyperpigmentation/Melasma Drugs by Geographical Region 2002-2011
- Figure 9-4: The Global Market for Prescription Hyperpigmentation/Melasma Drugs Revenues by Geographical Region 2002-2011
- Figure 9-5: The Global Market for Prescription Hyperpigmentation/Melasma Drugs, Share by Geographical Region 2006
- Figure 9-6: The Global Market for Prescription Hyperpigmentation/Melasma Drugs, Share by Geographical Region 2011
Chapter Ten: Prescription Psoriasis Drugs
- Table 10-1: Common Prescription Psoriasis Preparations
- Table 10-2: Prescription Psoriasis Preparations in Development
- Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 2002-2011
- Figure 10-1: The Global Market for Prescription Psoriasis DrugsRevenues by Type 2002-2011
- Figure 10-2: The Global Market for Prescription Psoriasis DrugsShare by Type 2006
- Figure 10-3: The Global Market for Prescription Psoriasis DrugsShare by Type 2011
- Table 10-5: The Global Market for Prescription Psoriasis Drugs by Geographical Region 2002-2011
- Figure 10-4: The Global Market for Prescription Psoriasis DrugsRevenues by Geographical Region 2002-2011
- Figure 10-5: The Global Market for Prescription Psoriasis DrugsShare by Geographical Region 2006
- Figure 10-6: The Global Market for Prescription Psoriasis DrugsShare by Geographical Region 2011
- Table 10-11: Global Market for Prescription Psoriasis Drugs Revenuesand Market Share by Supplier 2006
- Figure 10-7: Global Market for Prescription Psoriasis Drugs MarketShare by Leading Supplier 2006
Chapter Eleven: Prescription Skin Cancer Drugs
- Table 11-1: Malignant Conditions of the Skin
- Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
- Table 11-3: Prescription Skin Cancer Preparations in Development
- Table 11-4: The Global Market for Skin Cancer Drugs 2002-2011
- Figure 11-1: The Global Market for Skin Cancer Drugs 2002-2011
- Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 2002-2011
- Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 2002-2011
- Figure 11-3: The Global Market for Prescription Skin Cancer Drugs
- Share by Geographical Region 2006
- Figure 11-4: The Global Market for Prescription Skin Cancer DrugsShare by Geographical Region 2011
- Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2006
- Figure 11-9: Global Market for Skin Cancer Drugs Market Share byLeading Supplier 2006
Chapter Twelve: Miscellaneous Skin Disorder Drugs—Antivirals and Antiparasitics
- Table 12-1: Common Prescription Topical Antiviral Formulations
- Table 12-2: Common Prescription Topical Antiparasitic Formulations
- Table 12-3: The Global Market for Prescription Miscellaneous SkinDisorder Drugs by Type 2002-2011
- Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs Revenues by Type 2002-2006
- Table 12-5: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 2002-2011
- Figure 12-2: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 2002-2011
- Figure 12-3: The Global Market for Prescription Miscellaneous DrugsShare by Geographical Region 2006
- Figure 12-6: The Global Market for Prescription Miscellaneous DrugsShare by Geographical Region 2011
Chapter Thirteen: World Market Summary
- Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 2000-2011
- Figure 13-1: The Global Market for Prescription Dermatological Drugs Revenues by Dermatological Segment, 2002-2011
- Figure 13-2: The Global Market for Dermatological Drugs MarketShare by Type 2006
- Figure 13-3: The Global Market for Prescription Dermatological Drugs Market Share by Type 2011
- Table 13-3: Global Market for Prescription Dermatological DrugsRevenues and Segments of Participation by Leading Market Participants 2006
Download Table of Contents as a PDF
Other users found this report page using the following search terms: Acne Rosacea Dermatitis Seborrhea Melasma Psoriasis Skin Cancer melanoma market prescription size drugs dermatology dermatological hair topical acne drug
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.